Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
EnglishSvenskaNorsk
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mechanistic investigation of IRAK-3 immunomodulatory role in melanoma
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Medicinal Chemistry.
2022 (English)Independent thesis Advanced level (degree of Master (Two Years)), 30 credits / 45 HE creditsStudent thesis
Place, publisher, year, edition, pages
2022.
National Category
Cancer and Oncology Pharmaceutical Sciences Pharmacology and Toxicology Immunology in the medical area
Identifiers
URN: urn:nbn:se:uu:diva-481563OAI: oai:DiVA.org:uu-481563DiVA, id: diva2:1686998
Subject / course
Drug Development
Educational program
Master Programme in Drug Discovery and Development
Supervisors
Examiners
Available from: 2022-08-12 Created: 2022-08-12 Last updated: 2022-09-22Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
Department of Medicinal Chemistry
Cancer and OncologyPharmaceutical SciencesPharmacology and ToxicologyImmunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 201 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
v. 2.46.0
|
WCAG
|
Uppsala University Library
|
Ask the Library
|
Log in to DiVA
|
Search and link in DiVA